Nursing Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Nurs Crit Care. 2024 Nov;29(6):1303-1315. doi: 10.1111/nicc.13115. Epub 2024 Jul 3.
Decision aids (DAs) have been proposed to support patients and families with disease information processing and decision-making, but their effectiveness for critically ill patients and their families is incompletely understood.
To systematically synthesize evidence on the effectiveness of the DAs on the prognosis of critically ill patients and knowledge, anxiety, depression and decisional conflict of their family members.
Systematic review and meta-analysis. We conducted a systematic search of literature using PubMed, Embase, Cochrane Library, Web of Science, Cumulative Index to Nursing and Allied Health Literature database, Scopus, PsycNet, CNKI and Wanfang Database from the inception of the databases until May 2023 to identify randomized clinical trials (RCTs) describing DAs interventions targeted at adult intensive care unit (ICU) patients or their families. We also searched grey literature in four databases: Chinese Clinical Trials Registry, Chinese Cochrane Center, Open Grey and GreyNet International.
Seven RCTs were included in the review. Meta-analysis identified longer hospital length of stay (LOS) among all patients compared with usual care (mean difference [MD] = 5.64 days, 95% confidence interval, CI [0.29, 10.98], p = .04), but not in surviving patients (MD = 2.09 days, 95% CI [-3.70, 7.89], p = .48). However, there was no evidence of an effect of DAs on hospital mortality (RR = 1.25, 95% CI [0.92, 1.70], p = .15), ICU LOS (MD = 3.77 days, 95% CI [-0.17, 7.70], p = .06) and length of mechanical ventilation (MD = 0.88 days, 95% CI [-2.22, 3.97], p = .58). DAs led to a statistically significant improvement in family members' knowledge (standard mean difference = 0.84, 95% CI [0.12, 1.56], p = .02). We found no significant effect of DAs on anxiety, depression, post-traumatic stress disorder, decisional conflict and quality of communication of family members.
This review provides effective evidence that DAs can potentially improve the knowledge level of family members while prolonging the hospital LOS among critically ill patients.
Well-designed large-scale studies with DAs tailored to the individuals' preferences and existing cultural values are warranted.
决策辅助工具(DAs)已被提议用于支持患者及其家属处理疾病信息和做出决策,但对于危重症患者及其家属的有效性尚不完全清楚。
系统综合 DAs 对危重症患者预后以及其家属的知识、焦虑、抑郁和决策冲突的有效性证据。
系统综述和荟萃分析。我们使用 PubMed、Embase、Cochrane 图书馆、Web of Science、护理学和联合健康文献累积索引数据库、Scopus、PsycNet、CNKI 和万方数据库从数据库建立之初到 2023 年 5 月进行了系统的文献检索,以确定针对成人重症监护病房(ICU)患者或其家属的 DAs 干预措施的随机临床试验(RCTs)。我们还在四个数据库中搜索了灰色文献:中国临床试验注册中心、中国 Cochrane 中心、Open Grey 和 GreyNet International。
共纳入 7 项 RCT。荟萃分析发现,与常规护理相比,所有患者的住院时间(LOS)都更长(平均差值 [MD] = 5.64 天,95%置信区间,CI [0.29, 10.98],p =.04),但存活患者的 LOS 无差异(MD = 2.09 天,95% CI [-3.70, 7.89],p =.48)。然而,DAs 对医院死亡率(RR = 1.25,95% CI [0.92, 1.70],p =.15)、ICU LOS(MD = 3.77 天,95% CI [-0.17, 7.70],p =.06)和机械通气时间(MD = 0.88 天,95% CI [-2.22, 3.97],p =.58)均无影响。DAs 可显著提高家属的知识水平(标准均数差 = 0.84,95% CI [0.12, 1.56],p =.02)。我们未发现 DAs 对家属的焦虑、抑郁、创伤后应激障碍、决策冲突和沟通质量有显著影响。
本综述提供了有效的证据,表明 DAs 可能会提高危重症患者家属的知识水平,并延长其住院时间。
需要进行精心设计的、针对个体偏好和现有文化价值观进行定制的 DAs 的大型研究。